1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing links to a general funder page, not a specific grant program.
We recommend visiting the funder’s website directly to confirm this opportunity is available.
Search verified grants from Pfizer Foundation Inc. →This listing links to a general funder page, not a specific grant program.
The Antimicrobial Stewardship — Treatment Optimization grant for China is a program from the Pfizer Foundation that supports independent research, quality improvement, and education initiatives focused on improving antimicrobial stewardship and treatment optimization in Chinese healthcare settings. Pfizer Foundation grants fund initiatives aligned with areas of unmet medical need that improve patient outcomes in underserved communities.
Eligible applicants include medical schools and healthcare institutions operating in China. The application deadline for this cycle was March 31, 2026.
Get alerted about grants like this
Get emailed when new opportunities from “Pfizer Foundation Inc.” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Funding Global Health Through Grants Our grant programs support independent research, quality improvement and education initiatives that find innovative ways to improve patient outcomes in underserved communities around the world.
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s areas of interest. One Pediatric Gastroenterologist’s Mission to Expand Pediatric Treatment Options Dr. Nicole Kulisek shares her path from pediatric gastroenterologist to US Medical Affairs leader at Pfizer.
How Innovative Diagnostics Are Supporting a Potential Approach to C. difficile When scientists design a new vaccine candidate, they must also identify diagnostic tests that can be used to measure how effective that vaccine is.
Behind the Science: A New Path to Tackling Metastatic Breast Cancer In recent decades, advances in breast cancer treatment have helped to improve health outcomes for many patients, but scientists remain vigilant in their quest to further reduce both the incidence and impact of the disease.
Achieving breakthroughs that change patients’ lives across the globe, especially in underserved communities or disaster-affected communities, is our goal. Which is why we take the health and safety of our colleagues so seriously. We want to share the power of our resources to achieve a healthier world for everyone.
We’re committed to using everything at our disposal—from our medicines and vaccines, to our financial investments and colleagues’ expertise—all in the name of providing quality healthcare services for patients everywhere.
And because our resources allow us to reach so many people, we’re committed to using our global presence and scale to make a difference throughout the world Incredible things can happen when people come together with one shared goal. The future of medicine is happening here, and we’re eager to work alongside inspired and inspirational people who want to improve health around the world. Opportunities for Veterans Leadership.
Honor. A sense of purpose. The qualities you demonstrated as a member of the armed forces are valued at Pfizer.
Explore Veteran Opportunities We’re turning advanced science and technologies into therapies that make a real difference. Join us, and your efforts could impact millions of people. Breakthrough Fellowship Program We want to create a workplace for all.
That’s why we’re committed to increasing diversity and fostering inclusivity with this first-of-its-kind, nine-year fellowship program. Explore Our Fellowship Program Our ambitions are big and our product pipeline has never been stronger. We’re energized and inspired to apply science and our global resources to develop and deliver breakthrough therapies to people everywhere.
According to the current listing, eligibility includes: Medical schools and healthcare institutions in China. Confirm the full requirements in the official notice before applying.
The published deadline was March 31, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Antimicrobial Stewardship — Treatment Optimization - China is funded by Pfizer Foundation Inc.. Verify program details on the funder's official page before applying.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.